SE336198B - - Google Patents

Info

Publication number
SE336198B
SE336198B SE02196/65A SE219665A SE336198B SE 336198 B SE336198 B SE 336198B SE 02196/65 A SE02196/65 A SE 02196/65A SE 219665 A SE219665 A SE 219665A SE 336198 B SE336198 B SE 336198B
Authority
SE
Sweden
Prior art keywords
enzyme
venom
buffer
coagulant
freeze
Prior art date
Application number
SE02196/65A
Other languages
English (en)
Inventor
H Reid
M Esnouf
K Chan
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of SE336198B publication Critical patent/SE336198B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6418Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals from snakes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/803Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radar Systems Or Details Thereof (AREA)
SE02196/65A 1964-02-21 1965-02-19 SE336198B (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7264/64A GB1094301A (en) 1964-02-21 1964-02-21 Improvements relating to anticoagulants

Publications (1)

Publication Number Publication Date
SE336198B true SE336198B (xx) 1971-06-28

Family

ID=9829768

Family Applications (1)

Application Number Title Priority Date Filing Date
SE02196/65A SE336198B (xx) 1964-02-21 1965-02-19

Country Status (13)

Country Link
US (1) US3657416A (xx)
AT (1) AT266313B (xx)
BE (1) BE659856A (xx)
BR (1) BR6567297D0 (xx)
CH (1) CH453580A (xx)
DE (1) DE1442134C3 (xx)
DK (1) DK114995B (xx)
ES (1) ES309630A1 (xx)
FR (1) FR4655M (xx)
GB (1) GB1094301A (xx)
NL (1) NL139231B (xx)
NO (1) NO119903B (xx)
SE (1) SE336198B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH586233A5 (xx) * 1971-01-18 1977-03-31 Pentapharm Ag
BE786788A (fr) * 1971-07-27 1973-01-26 Rhone Poulenc Sa Nouvelle enzyme thrombolytique et sa preparation par fermentation d'un streptomyces
US4086140A (en) * 1972-04-05 1978-04-25 John Burnham King Process for isolating fibrinolytic substances
US4039658A (en) * 1972-04-05 1977-08-02 John Burnham King Fibrinolytic substances
US3879369A (en) * 1972-05-12 1975-04-22 Abbott Lab Anti-coagulant isolation from malayan pit viper using affinity chromatography
SE420321B (sv) * 1973-09-03 1981-09-28 Fargal Pharmasint Lab Biochim Kromatografisk extraktion och isolering av enzymatisk komponent fran ormgift
US6613324B1 (en) * 1991-02-28 2003-09-02 Bristol-Myers Squibb Company Adhesive for the gluing of biological tissues
DE19607210A1 (de) * 1996-02-26 1997-08-28 Knoll Ag Verfahren zur Reinigung von thrombinähnlichen Proteasen aus Schlangengiften
CN113164564A (zh) * 2018-11-19 2021-07-23 诺尔玛克Ip股份有限公司 用于治疗或预防心内膜炎的安克洛酶

Also Published As

Publication number Publication date
DE1442134B2 (de) 1974-04-25
CH453580A (fr) 1968-06-14
DE1442134A1 (de) 1969-03-06
NO119903B (xx) 1970-07-27
FR4655M (xx) 1966-12-12
NL6502120A (xx) 1965-08-23
ES309630A1 (es) 1965-12-16
DE1442134C3 (de) 1974-12-12
BR6567297D0 (pt) 1973-08-14
GB1094301A (en) 1967-12-06
AT266313B (de) 1968-11-11
BE659856A (xx) 1965-08-17
US3657416A (en) 1972-04-18
DK114995B (da) 1969-08-25
NL139231B (nl) 1973-07-16

Similar Documents

Publication Publication Date Title
Rijken et al. Relationship between tissue plasminogen activator and the activators in blood and vascular wall
Pineo et al. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas
Seegers Prothrombin
Radcliffe et al. Isolation of plasminogen activator from human plasma by chromatography on lysine-Sepharose
DK0477274T3 (da) Faktor Xa baserede antikoaguleringspræparater
Fantl et al. Fibrinolysis following electrically induced convulsions.
US3743722A (en) Anti-coagulant isolation
Colman et al. [12] Factor V
SE336198B (xx)
Sakata et al. Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency
US6068838A (en) Purified multimerase
Kowalski et al. Circulating fibrinogen degradation products (FDP) in dog blood after intravenous thrombin infusion
Cash et al. Studies on the thrombogenicity of Scottish factor IX concentrates in dogs
Kelen et al. Fibrinogenolytic substance (Hementerin) of Brazilian blood-sucking leeches (Haementeria lutzi Pinto 1920)
Egberg et al. Effects of Reptilase‐Induced Intravascular Coagulation in Dogs
Damus et al. A purified procoagulant enzyme from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus): In vivo and in vitro studies
Pepper et al. In vitro thrombogenicity tests of factor IX concentrates
Tagnon et al. The coagulation defect in hemophilia: a comparison of the proteolytic activity of chloroform preparations of hemophilic and normal human plasma
Brink et al. Effects of puff-adder venom on coagulation, fibrinolysis and platelet aggregation in the baboon
US4154656A (en) Method for determining the fibrinogen content of physiological liquid
EP0239644A1 (en) Novel physiologically active substance having blood coagulation controlling activity
Hamilton et al. Coagulant activity of the scorpion venoms Palamneus gravimanus and Leiurus quinquestriatus
Egberg et al. In vivo effect of Reptilase on fibrinogen metabolism in dogs
Ratnoff A. The Physiology of Blood Coagulation
Cartwright Partial purification of a specific plasminogen activator from porcine parotid glands